12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights 1 hour ago
Movers
Gainers Lisata Therapeutics (NASDAQ:LSTA) stock rose 37.2% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million. BioStem Technologies (NASDAQ:BSEM) shares
Gainers
- Lisata Therapeutics (NASDAQ:LSTA) stock rose 37.2% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million.
- BioStem Technologies (NASDAQ:BSEM) shares moved upwards by 32.21% to $1.38. The market value of their outstanding shares is at $19.4 million.
- CervoMed (NASDAQ:CRVO) stock increased by 31.02% to $1.79. The market value of their outstanding shares is at $20.7 million. As per the press release, Q3 earnings came out 3 days ago.
- Cellectis (NASDAQ:CLLS) stock rose 28.82% to $1.43. The company's market cap stands at $111.8 million.
- Yarrow Bioscience (NASDAQ:YARW) shares increased by 22.73% to $19.0. The market value of their outstanding shares is at $130.6 million.
- Cumberland Pharma (NASDAQ:CPIX) stock rose 21.88% to $6.46. The company's market cap stands at $79.4 million. The company's, Q3 earnings came out yesterday.
Losers
- Basel Medical Group (NASDAQ:BMGL) stock declined by 64.5% to $0.69 during Wednesday's regular session. The company's market cap stands at $26.2 million.
- Aptevo Therapeutics (NASDAQ:APVO) stock decreased by 30.15% to $0.75. The market value of their outstanding shares is at $1.9 million.
- SL Science Holding (NASDAQ:SLBT) stock decreased by 24.97% to $0.67. The company's market cap stands at $504.1 million.
- Bio Green Med Solution (NASDAQ:BGMS) stock fell 24.81% to $0.6. The market value of their outstanding shares is at $5.3 million.
- Eocene (NASDAQ:EOCN) stock fell 20.38% to $2.15. The company's market cap stands at $2.8 million.
- Autonomix Medical (NASDAQ:AMIX) shares fell 20.01% to $1.48. The company's market cap stands at $3.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
